Physitrack Reports 14% Q3 Revenue Growth to €3.6 Million as U.S. Expansion Accelerates
Physitrack plc (OMXSTO:PTRK) reported a 14% year-over-year increase in third-quarter 2026 revenue to €3.6 million, backed by 11% growth on a constant-currency basis. The digital healthcare company generated adjusted EBITDA of €1.1 million, maintaining a 31% operating margin, while shares rose 10.00% to 12.1 SEK following the release.
The solid results were driven primarily by the company's core Lifecare division, which saw revenue rise 15% to €3.3 million. Software-as-a-service subscriptions accounted for 93% of the division's business, supporting an 89.2% gross margin and ongoing positive operating cash flow. Customer retention remained firm, reflected in a 99.3% net revenue retention rate and a low monthly churn rate of 1.0%.
Commercial progress in North America provided a notable boost, highlighted by new contracts with two U.S. health systems utilizing Epic and MyChart integration. Investors will look ahead to early 2027, when Physitrack plans to begin monetizing its new electronic medical record access program, which currently includes 470 clinics and 4,700 users.
Key points
- Q3 2026 revenue grew 14% year-over-year to €3.6 million, or 11% on a constant-currency basis.
- Adjusted EBITDA reached €1.1 million, representing a 31% margin alongside continued positive operating cash flow.
- Lifecare revenue climbed 15% to €3.3 million, with subscription software generating 93% of division sales.
- Two U.S. health systems adopted Physitrack, expanding commercial reach in North America.
- Early access for new electronic medical record tools registered 470 clinics and 4,700 users ahead of planned monetization in 2027.
Written by our AI from expert market sources across the web. It can contain mistakes: check the facts before acting on them. Write-ups powered by the free AI API at FreeTheAI.org
How we writeDisclaimerQuestions and answers
What were Physitrack's Q3 2026 financial results?
Physitrack reported Q3 2026 revenue of €3.6 million, up 14% year-over-year, and adjusted EBITDA of €1.1 million with a 31% margin.
How did Physitrack perform in the U.S. market during Q3 2026?
Physitrack secured contracts with two U.S. health systems featuring Epic and MyChart integration, while expanding early access for its electronic medical record tools to 470 clinics.
When will Physitrack begin monetizing its new EMR platform?
Monetization for Physitrack's new electronic medical record program is scheduled to begin on January 1, 2027.